M. G. Calori, R. Capanna, and M. Colombo, Cost effectiveness of tibial nonunion treatment: a comparison between rhBMP-7 and autologous bone graft in two Italian centres, Injury, vol.44, issue.12, pp.1871-1879, 2013.

T. J. Blokhuis, G. M. Calori, and G. Schmidmaier, Autograft versus BMPs for the treatment of non-unions: what is the evidence?, Injury, vol.44, pp.40-42, 2013.

M. Bhandari, G. H. Guyatt, M. F. Swiontkowski, P. Tornetta, I. et al., A lack of consensus in the assessment of fracture healing among orthopaedic surgeons, Journal of Orthopaedic Trauma, vol.16, issue.8, pp.562-566, 2002.

, Food and Drug Administration and US Department of Health and Human Services, Guidance Document for Industry and CDRH Staff for the Preparation of Investigational Device Exemptions and Premarket Approval Applications for Bone Growth Stimulator Devices, US Food and Drug Administration, 1998.

J. A. Bishop, A. A. Palanca, M. J. Bellino, and D. W. Lowenberg, Assessment of compromised fracture healing, Journal of the American Academy of Orthopaedic Surgeons, vol.20, issue.5, pp.273-282, 2012.

M. E. Müller, M. Allgöwer, R. Schneider, and H. Willenegger, Manual of Internal Fixation, 1991.

P. Hernigou, A. Desroches, and S. Queinnec, Morbidity of graft harvesting versus bone marrow aspiration in cell regenerative therapy, International Orthopaedics, vol.38, issue.9, pp.1855-1860, 2014.

G. E. Friedlaender, C. R. Perry, and J. D. Cole, Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions, The Journal of Bone and Joint SurgeryAmerican, vol.83, pp.151-158, 2001.

E. Gómez-barrena, P. Rosset, and I. Müller, Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology, Journal of Cellular and Molecular Medicine, vol.15, issue.6, pp.1266-1286, 2011.

E. Gómez-barrena, P. Rosset, D. Lozano, J. Stanovici, C. Ermthaller et al., Bone fracture healing: cell therapy in delayed unions and nonunions, Bone, vol.70, pp.93-101, 2015.

A. European-medicines, Scientific Guidelines for Human Medicinal Products, Clinical Efficacy and Safety Guidelines, General Guidelines

E. Veronesi, A. Murgia, and A. Caselli, Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/ stem cells for bone regeneration, Tissue Engineering Part C: Methods, vol.20, issue.3, pp.239-251, 2014.

M. A. Brennan, A. Renaud, and J. Amiaud, Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate, Stem Cell Research & Therapy, vol.5, issue.5, p.114, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01205389

A. E. Rapp, R. Bindl, and S. , Fracture Healing Is Delayed in Immunodeficient NOD/scid-IL2R? c null Mice, PLoS One, vol.11, issue.2, p.147465, 2016.

G. Bassi, F. Guilloton, and C. Menard, Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin, Tissue Engineering Part A, vol.21, issue.3-4, pp.767-781, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01076081

T. Miramond, P. Corre, and P. Borget, Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model, Journal of Biomaterials Applications, vol.29, issue.4, pp.595-604, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01848692

A. L. Gamblin, M. A. Brennan, and A. Renaud, Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages, Biomaterials, vol.35, issue.36, pp.9660-9667, 2014.

M. Mebarki, L. Coquelin, and P. Layrolle, Enhanced human bone marrow mesenchymal stromal cell adhesion on scaffolds promotes cell survival and bone formation, Acta Biomaterialia, vol.59, pp.94-107, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01577907

N. Fekete, M. Gadelorge, and D. Fürst, Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components, Cytotherapy, vol.14, issue.5, pp.540-554, 2012.

J. Léotot, A. Lebouvier, P. Hernigou, P. Bierling, H. Rouard et al., Bone-forming capacity and biodistribution of bone marrow-derived stromal cells directly loaded into scaffolds: a novel and easy approach for clinical application of bone regeneration, Cell Transplantation, vol.24, issue.10, pp.1945-1955, 2015.

D. Machin and M. J. Campbell, Statistical Tables for Design of, Clinical Trials, 1987.

J. L. Fleiss, A. Tytun, and H. K. Ury, A simple approximation for calculating sample sizes for comparing independent proportions, Biometrics, vol.36, issue.2, pp.343-346, 1980.

D. Hauschke, M. Kieser, E. Diletti, and M. Burke, Sample size determination for proving equivalence based on the ratio of two means for normally distributed data, Statistics in Medicine, vol.18, issue.1, pp.93-105, 1999.

J. D. Elashoff, Advisor User's Guide, Statistical Solutions Ltd, 2007.

M. Liebergall, J. Schroeder, and R. Mosheiff, Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study, Molecular Therapy, vol.21, issue.8, pp.1631-1639, 2013.

M. A. Tressler, J. E. Richards, D. Sofianos, F. K. Comrie, P. J. Kregor et al., Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion, Orthopedics, vol.34, issue.12, pp.877-884, 2011.

, Stem Cells International

J. A. Goulet, L. E. Senunas, G. L. Desilva, and M. L. Greenfield, Autogenous iliac crest bone graft: Complications and functional assessment, Clinical Orthopaedics and Related Research, vol.339, pp.76-81, 1997.

M. K. Sen and T. Miclau, Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?, Injury, vol.38, issue.1, pp.75-80, 2007.

S. Bajada, P. E. Harrison, B. A. Ashton, V. N. Cassar-pullicino, N. Ashammakhi et al., Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation, Journal of Bone and Joint Surgery -British, issue.10, pp.1382-1386, 2007.

S. Giannotti, V. Bottai, and M. Ghilardi, Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study, European Review for Medical and Pharmacological Sciences, vol.17, issue.2, pp.224-227, 2013.

H. D. Ismail, P. Phedy, and E. Kholinne, Mesenchymal stem cell implantation in atrophic nonunion of the long bones: a translational study, Bone & Joint Research, vol.5, issue.7, pp.287-293, 2016.

M. Marcacci, E. Kon, and V. Moukhachev, Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study, Tissue Engineering, vol.13, issue.5, pp.947-955, 2007.

I. H. Dilogo, A. F. Kamal, B. Gunawan, and R. V. Rawung, Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia, International Journal of Surgery Case Reports, vol.17, pp.106-111, 2015.

N. Labibzadeh, M. Emadedin, and R. Fazeli, Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion, Cell Journal, vol.18, issue.3, pp.302-309, 2016.

E. Gomez-barrena, C. A. Sola, and C. P. Bunu, Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells, International Orthopaedics, vol.38, issue.9, pp.1803-1812, 2014.

M. P. Jensen, C. Chen, and A. M. Brugger, Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain, The Journal of Pain, vol.4, issue.7, pp.407-414, 2003.

, Stem Cells International